Throughout 2025, AbbVie’s Skyrizi and Johnson & Johnson’s Tremfya were mainstays at the top of the monthly TV drug ad ...
Vicks accrued a total of 4.3 billion impressions on an estimated national TV ad spend of $18.9 million. The top network for ...
Tremfya’s reign atop the TV pharma ad rankings continued for yet another month as the Johnson & Johnson brand topped iSpot.tv’s list for October. Tremyfa achieved an impressions share of voice (SOV) ...